"Treatment with tesamorelin significantly improves visceral fat accumulation in patients with HIV, an international team of investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes.
"Preliminary results of the study were reported at the 2008 International Conference in Mexico City.
"The results of a 26-week study, followed by a further six-months of analysis showed that therapy with the drug reduced levels of visceral fat and waist circumference without having detrimental metabolic effects."
Read more in Aidsnews, February 3, 2010.
0 comments:
Post a Comment